ABBV-711
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-711, covering 2026-02-17 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors [Phase 1]